Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial

Alvin Shrestha (Lead / Corresponding author), Tufail Bashir, Marcus Achison, Simon Adamson, Asangaedem Akpan, Terry Aspray, Alison Avenell, Margaret M. Band, Louise A. Burton, Vera Cvoro, Peter T. Donnan, Gordon W. Duncan, Jacob George, Adam L. Gordon, Celia L. Gregson, Adrian Hapca, Cheryl Hume, Thomas A. Jackson, Simon Kerr, Alixe KilgourTahir Masud, Andrew McKenzie, Emma McKenzie, Harnish Patel, Kristina Pilvinyte, Helen C. Roberts, Avan A. Sayer, Christos Rossios, Karen Smith, Roy L. Soiza, Claire J. Steves, Allan Struthers, Divya Tiwari, Julie Whitney, Miles D. Witham, Paul R. Kemp

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

51 Downloads (Pure)

1 results

Filter

Finished
Leucine and ACE Inhibitors as Therapies for Sarcopenia; a Two by Two Factorial Randomised Placebo Controlled Trial (Joint with NHS Tayside, Imperial College London and University of Aberdeen)
Donnan, P. (Investigator), George, J. (Investigator), McMurdo, M. (Investigator), Struthers, A. (Investigator), Sumukadas, D. (Investigator) & Witham, M. (Investigator)
1/11/15 → 31/03/21
Project: Research

Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial

Projects

Search results

Leucine and ACE Inhibitors as Therapies for Sarcopenia; a Two by Two Factorial Randomised Placebo Controlled Trial (Joint with NHS Tayside, Imperial College London and University of Aberdeen)